April 2024 - Page 2 of 3 - BioMedWire (BMW)

WednesdayApr 17, 2024 10:00 am

New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People

A recently published review has found that social vulnerability and frailty worsen as individuals age. When both are present, these conditions result in a considerably heightened decline in cognitive and physical function as well as mortality risk. So, what is frailty? Theoretically, frailty is defined as a state of heightened vulnerability resulting from declines associated with age that is clinically recognizable. These declines often compromise an individual’s ability to cope with acute stressors, with researchers noting that frailty is common among older people. While advancements in modern medicine have significantly improved life expectancy of humans beyond natural limits, frailty remains…

TuesdayApr 16, 2024 9:45 am

Astiva Health Inc. Committed to Creating Healthcare Model Focused on Collaboration Between Physician and Patient

Duke reports that physician-patient relationships can have profound positive and negative implications on clinical care” The dynamic between a physician and patient can be impacted by the ability to speak articulately, including the knowledge of a foreign language, and racial and cultural differences Astiva Health specializes in innovative health plans tailored to meet the unique requirements of its members Astiva Health has a network of providers that closely matches patients’ demographic background, interest, language and culture. This does not come by luck. Astiva has always been working on improving its provider network and physician-patient assignment, ensuring health plans align with client…

MondayApr 15, 2024 10:00 am

Study Identifies Three Distinct Subtypes of Multiple Sclerosis

Multiple sclerosis (MS) is a chronic illness that affects an individual’s central nervous system. The disease manifests differently in each individual and has varying trajectories, which makes it difficult to manage. It also has no cure. New research has identified three subtypes of the disease based on immune markers observed in participants’ blood. For the research, a team of investigators led by Professor Heinz Wiendl, a professor at the University of Münster, conducted a comprehensive analysis of the immunological properties of different blood samples collected from more than 300 early multiple sclerosis patients and a validation group made up of…

FridayApr 12, 2024 10:00 am

Study Finds Presurgery Immunotherapy Safe for Patients with Pancreatic Cancer

Pancreatic cancer is a challenging cancer to treat. Research shows that roughly 12% of individuals diagnosed with this particular cancer live beyond five years. Additionally, treatments such as chemotherapy, immunotherapy and targeted therapies are unsuccessful in treating pancreatic cancer. Prior research has determined that combined PD1-inhibitors and chemotherapy hasn’t brought any improvements in pancreatic cancer patients. PD1-inhibitors are an immunotherapy drug that assists the immune system in recognizing and eliminating cancer cells effectively. Now, new research suggests that individuals with pancreatic cancer can undergo immunotherapy prior to surgery, with scientists noting that this may improve long-term outcomes. The research was…

WednesdayApr 10, 2024 10:00 am

Hackers Exploit Bug in Magento to Access Payment Data on eCommerce Sites

A critical flaw in the open-source e-commerce platform Magento has allowed hackers to make backdoors into e-commerce websites and steal payment data. Computer software company Adobe Inc. describes the error, CVE-2024-2072, as the “improper neutralization of special elements” that could allow attackers to make arbitrary code executions without any user interaction. Adobe addressed the vulnerability on Feb. 13, 2024, as part of a batch of security updates while e-commerce security company Sansec announced that it had found a database layout template that was used to “inject malicious code” automatically. Hackers could then use this code to execute commands arbitrarily by…

WednesdayApr 10, 2024 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients AVERSA technology can be incorporated into any transdermal patch The company has a broad intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico and Australia Nutriband announced in March 2024 that it will submit a New Drug Application to the FDA seeking approval to market AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch In April 2024, the company announced it had received a contract manufacturing order from…

TuesdayApr 09, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) has Emerged as a Leader in the Neurodegenerative Field Utilizing a Novel Nanotherapeutic Drug

Clinical trials of Clene’s lead candidate CNM-Au8(R) have shown notable success in crossing the blood-brain barrier and enhancing the brain's bioenergetic metabolites, essentially "reversing the clock" on what would be considered healthy aging CNM-Au8 has shown promise in clinical trials for both ALS and MS, including improvements in survival rates and clinical function Clene was recently featured in an interview of CEO Rob Etherington on ‘First in Human’ podcast In a significant advancement for the treatment of neurodegenerative diseases, Clene (NASDAQ: CLNN) has innovated CNM-Au8, an oral nanotherapeutic designed to revitalize the brain's mitochondrial function. The potential of this drug…

MondayApr 08, 2024 10:00 am

Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors

Scientists at the National Agency for Medicines and Health Products Safety in France recently linked the use of hormone treatments by women to a heightened risk of women developing benign brain tumors. During their research, they determined that prolonged use of some progestogen drugs was associated with a higher risk of meningioma. This sentiment isn’t shared by all, however, with one leading expert noting that while the risk of meningioma was higher in women who took the drugs for more than one year, the finding need not worry present or past users as heightened risk remained small. Meningiomas are common…

FridayApr 05, 2024 10:30 am

Astiva Health Inc. — Bridging Healthcare Gaps with Proactive, Culturally Responsive Solutions

A Brookings Institution report indicates significant racial disparities in access to health coverage and in health outcomes Astiva Health is focused on reshaping the landscape of personalized and comprehensive healthcare The company carefully considers needs of its members, creates plans that feature cultural strategies for diverse ethnic groups In a world where racial disparities still run rampant in many ways, including health coverage and outcomes, Astiva Health is focused on meeting the healthcare needs of underserved populations. The company recognizes the diverse challenges within key communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions. “In the…

FridayApr 05, 2024 10:00 am

Google Develops AI System to Leverage Sound in Detecting Lung Ailments

Health acoustic sounds contain useful health signals that have the potential to aid in health monitoring as well as disease diagnosis. Recently, scientists at Google Research, in collaboration with researchers at Zambia’s Center of Infectious Disease Research, developed an AI system that can use coughing sounds to diagnose lung disease. The system, called Health Acoustic Representations (HeAR), is available as a preprint on arXiv. The investigators started working on the system after healthcare professionals reported that over time, they had learned to tell which patients had coronavirus by how their coughs sounded. For their study, they used an approach similar…